EurekAlert!

Collaboration key to tackling rare blood cancers

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for ...
ascopubs.org

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial 3'RNA sequencing was performed in 1,733 ...
EurekAlert!

An interpretable machine learning model for predicting 5‐year survival in breast cancer based on integration of proteomics and clinical data

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...
ascopubs.org

Re-Evaluating Established Prognostic Models in the Era of Immunotherapy in Renal Cell Carcinoma

Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT) However, the prognostic value of the IMDC model for ICI-treated patients ...
News Medical

IMDC prognostic model valid in second-line RCC therapy

The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model can be applied to metastatic renal cell carcinoma (RCC) patients receiving second-line targeted treatment, ...